➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Express Scripts
Dow
McKinsey
Colorcon

Last Updated: September 24, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR OXYCODONE AND ASPIRIN (HALF-STRENGTH)

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Oxycodone And Aspirin (half-strength)

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00771758 ↗ Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis Completed Grünenthal GmbH Phase 3 2008-09-01 The purpose of this study is to determine the effectiveness and safety of tapentadol immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom treatment with oral opioid analgesics is appropriate.
NCT00771758 ↗ Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis Completed Ortho-McNeil Janssen Scientific Affairs, LLC Phase 3 2008-09-01 The purpose of this study is to determine the effectiveness and safety of tapentadol immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom treatment with oral opioid analgesics is appropriate.
NCT00814580 ↗ Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery Completed Grünenthal GmbH Phase 3 2008-12-01 The purpose of this study is to evaluate how tapentadol immediate release (IR) and oxycodone IR treat moderate to severe post-operative pain after elective arthroscopic shoulder surgery.
NCT00814580 ↗ Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery Completed Ortho-McNeil Janssen Scientific Affairs, LLC Phase 3 2008-12-01 The purpose of this study is to evaluate how tapentadol immediate release (IR) and oxycodone IR treat moderate to severe post-operative pain after elective arthroscopic shoulder surgery.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Oxycodone And Aspirin (half-strength)

Condition Name

Condition Name for Oxycodone And Aspirin (half-strength)
Intervention Trials
Migraine Disorders 1
Essential Thrombocythemia 1
Back Pain 1
Tranexamic Acid Adverse Reaction 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Oxycodone And Aspirin (half-strength)
Intervention Trials
Pain, Postoperative 2
Osteoporosis 1
Thrombocytosis 1
Fractures, Compression 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Oxycodone And Aspirin (half-strength)

Trials by Country

Trials by Country for Oxycodone And Aspirin (half-strength)
Location Trials
United States 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Oxycodone And Aspirin (half-strength)
Location Trials
New York 3
North Carolina 3
California 2
Arizona 2
Louisiana 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Oxycodone And Aspirin (half-strength)

Clinical Trial Phase

Clinical Trial Phase for Oxycodone And Aspirin (half-strength)
Clinical Trial Phase Trials
Phase 4 2
Phase 3 2
Phase 2 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Oxycodone And Aspirin (half-strength)
Clinical Trial Phase Trials
Completed 3
Recruiting 2
Suspended 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Oxycodone And Aspirin (half-strength)

Sponsor Name

Sponsor Name for Oxycodone And Aspirin (half-strength)
Sponsor Trials
Ortho-McNeil Janssen Scientific Affairs, LLC 2
Grünenthal GmbH 2
Genentech, Inc. 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Oxycodone And Aspirin (half-strength)
Sponsor Trials
Industry 6
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Express Scripts
McKesson
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.